How Much Does A Placenta Cost?

Last updated on May 17, 2026 | Written by Alec Pow
This article was researched using 8 sources. See our methodology and corrections policy.

TLDR: The viral claim that parents can sell a placenta for tens of thousands of dollars has no support from any U.S. government, medical, or tissue-bank source. The real consumer-facing cost is $250–$450 for optional encapsulation services, paid by the parent to a private provider.

How Much Does A Placenta Cost?

Jump to sections

• Base placenta encapsulation service: $350 (Midwest Placenta Encapsulation, 2025)
• Encapsulation with add-ons (keepsakes, tinctures, prints): $400–$600+ depending on provider
• Placenta donation to a tissue bank: $0 cost and $0 payment to the parent
• Legal open-market resale to a private buyer: not permitted under U.S. tissue regulations
• Viral “worth” figures cited on social media (e.g., $50,000): unsupported by any authoritative source found in research

Placenta pricing only makes practical sense when you separate three completely different contexts: what a parent pays a private service provider to process a placenta after birth, what tissue banks do with donated placentas at no cost to anyone, and what the law actually allows regarding sale. Each path has a distinct cost structure and a distinct set of risks.

What you’re actually buying

A placenta is the organ that develops during pregnancy to supply oxygen and nutrients to a fetus. It is delivered after the baby and handled by the hospital as biological waste unless the parent requests otherwise. It is not a commodity with a spot price, a regulated resale market, or a standardized consumer value.

The only transaction most parents will ever encounter is paying for encapsulation or keepsake preservation, a private, unregulated service market with tiered pricing and documented safety concerns. The idea of receiving money for a placenta runs directly into federal tissue-handling rules and the position of every major U.S. health institution reviewed for this article.

A worked example

A parent in the Midwest who decides to keep and encapsulate their placenta after a hospital birth can expect to pay roughly the following, based on published provider pricing as of late 2025.

Midwest Placenta Encapsulation lists a Basic Encapsulation Service at $350. That base price covers pickup or drop-off coordination, dehydration, grinding, and capsule filling. Optional add-ons listed separately on the same page include keepsake items such as a placenta print or a dried-cord keepsake, and additional preservation options that push the total higher. Mommy Made Encapsulation’s current pricing page shows a similar tiered structure, with shipping and handling as a separate line item for parents who mail the placenta rather than use local pickup.

A realistic all-in total for a parent choosing the base capsule service plus one keepsake and local pickup coordination runs $375–$420. Adding a tincture, a cord keepsake, and a printed certificate can push that to $500–$575. These figures are computed from the published base rates plus the add-on ranges shown on both provider pages. No single national price exists because this is an unregulated private service market with no licensing body and no published industry-wide fee schedule.

Pathway	Cost to parent	Payment to parent	Legal status
Hospital disposal	$0	$0	Standard default
Tissue bank donation	$0	$0	Permitted, no compensation
Encapsulation / keepsake service	$250–$600+	$0	Unregulated private service
Private resale	N/A	Not legally supported	Blocked by U.S. tissue rules

What the $50,000 figure refers to

Social media posts and clickbait summaries have circulated figures as high as $50,000 as the supposed worth of a human placenta. No authoritative government, medical, or tissue-bank source found in the research for this article supports that figure as a legal open-market price paid to a parent. The Parent’s Guide to Cord Blood Foundation states plainly that you cannot sell a placenta in the United States, noting that placentas collected in healthcare settings fall under waste, tissue, and donation rules rather than commercial property rules.

Where do the large numbers come from? Placental tissue has documented downstream value in biomedical manufacturing. Amniotic membrane products, growth factor extracts, and wound care grafts are all derived from placental or amniotic tissue in licensed processing facilities. The commercial value of those finished medical products is real, but it accrues to licensed processors and manufacturers operating under FDA oversight, not to the birth parent. The gap between tissue having biomedical value in a supply chain and being able to sell yours for $50,000 is the gap between a wholesale ingredient price at a regulated facility and a consumer transaction that does not legally exist.

Why U.S. law blocks private placenta sales

The National Organ Transplant Act of 1984 prohibits the sale of human organs and certain human tissues for valuable consideration. Human placental tissue falls within the regulatory scope the FDA oversees under its authority over human cells, tissues, and cellular and tissue-based products. On September 4, 2024, the FDA issued a patient and consumer warning about unapproved products derived from human cells or tissues, naming human placental tissue-derived products as a category of concern. That warning reinforces that products marketed without required FDA review may pose serious safety risks, and that the commercial pathway for such products runs through regulated channels, not private transactions.

Gift of Life Michigan, a U.S. tissue donation organization, addressed this question directly in a June 2025 post. Their page states that there is no payment for donating a placenta and describes donation as a no-cost option for parents whose placentas may support healing applications and research. The language is consistent across every nonprofit and medical source reviewed: donation is possible, compensation is not.

The encapsulation market

Placenta encapsulation is a private, unregulated service. No U.S. state licensing board certifies placenta encapsulators as of the research date for this article. Providers set their own prices, their own processing standards, and their own add-on menus. The base service, covering dehydration, grinding, and capsule filling, is the common denominator, but the process varies by provider and is not subject to any standardized food safety or pharmaceutical manufacturing protocol.

Pricing varies by region and by the provider’s service model. The $350 base rate at Midwest Placenta Encapsulation represents one of the more transparent published prices in the market. Providers in higher-cost metro areas charge $300–$500 for base encapsulation alone, with keepsakes and tinctures adding another $50–$150 per item. Travel fees for pickup and delivery, rush processing charges, and shipping costs for parents who mail the placenta are additional line items that do not always appear prominently on provider websites.

What the evidence says

Proponents of placenta encapsulation claim it supports postpartum recovery, reduces the risk of postpartum depression, boosts milk supply, and replenishes iron. Cleveland Clinic reviewed the evidence as of May 2025 and found that support for these claimed benefits is weak. No large randomized controlled trials have established clinical efficacy for any of the commonly cited outcomes. Cleveland Clinic describes encapsulation as the process of drying, powdering, and placing placenta into capsules for ingestion, and notes that infection is the biggest documented risk associated with the practice.

The American College of Obstetricians and Gynecologists addressed placenta accreta spectrum as a serious obstetric condition requiring clinical management at higher-acuity centers, as documented in its December 2018 obstetric care consensus. That guidance reinforces that placenta-related clinical decisions belong in medical settings, not in the unregulated consumer services market. No ACOG committee opinion squarely dedicated to placentophagy was found in the research for this article, so risk framing here relies primarily on CDC, FDA, and Cleveland Clinic sources.

The documented infection risk

The most concrete safety data point in the public record is a CDC case report published in the Morbidity and Mortality Weekly Report on June 30, 2017. The report documents a late-onset infant Group B Streptococcus infection in Oregon in 2016 that the CDC linked to maternal consumption of dehydrated placenta capsules. The CDC’s conclusion was direct: the encapsulation process does not necessarily eliminate infectious pathogens, and placenta capsule ingestion can heighten maternal colonization and increase infant risk. The CDC advised that this practice should be avoided.

That case report remains the clearest evidence-based reason for caution. A newborn in the same household as a parent consuming contaminated placenta capsules can be exposed to Group B Streptococcus through close contact and breastfeeding. The risk is not theoretical. The FDA’s September 2024 warning about unapproved human cell and tissue products adds a regulatory layer to the same concern: products derived from human tissue and marketed without required review may carry safety risks that consumers cannot assess from a provider’s website or marketing materials.

Who this cost makes sense for

Makes sense if:

• You have discussed encapsulation with your OB or midwife and received individualized guidance on your specific postpartum health situation.
• You understand that claimed benefits are not clinically established and are treating encapsulation as a personal or cultural choice rather than a medical treatment.
• Your newborn does not have a condition that increases Group B Streptococcus vulnerability, and your provider has confirmed no active infection risk in your case.
• You have verified that your hospital or birth center will release the placenta to you and that you have a logistics plan for transport and handoff to the encapsulator.
• You have a written quote that itemizes the base service, add-ons, and any transport or rush fees before committing.

Doesn’t make sense if:

• You are expecting encapsulation to substitute for medical postpartum care, including treatment for postpartum depression or documented iron deficiency.
• Your hospital’s policy does not permit placenta release, or you have not confirmed the logistics in advance.
• You are relying on social media claims about resale value as a financial reason to retain the placenta. Those claims are not supported by any authoritative source reviewed here.
• Your OB has identified any infection risk, Group B Streptococcus colonization, or other clinical factor that makes placenta consumption inadvisable for your situation.

Cord blood banking is a related decision that some parents face at the same time. A look at cord blood banking costs shows a similarly tiered private market with significant variation between providers.

Verification

• Confirmed that Midwest Placenta Encapsulation lists a $350 base encapsulation service on its current pricing page: Midwest Placenta Encapsulation pricing.
• Checked that Mommy Made Encapsulation’s pricing structure as of August 2025 uses multiple tiers and add-ons rather than a single flat rate: Mommy Made Encapsulation services and pricing.
• Cross-referenced the CDC’s June 2017 MMWR case report documenting a late-onset infant Group B Streptococcus infection associated with maternal placenta capsule consumption in Oregon, 2016: CDC MMWR placenta capsule infection report.
• Verified that the FDA issued a consumer warning on September 4, 2024, covering unapproved products derived from human cells and tissues, including placental tissue-derived products: FDA unapproved human tissue product warning.
• Confirmed that Gift of Life Michigan’s June 2025 explainer states no payment is made to parents for placenta donation: Gift of Life Michigan placenta donation FAQ.
• Cross-referenced Cleveland Clinic’s May 2025 review finding weak evidence for encapsulation benefits and identifying infection as the primary documented risk: Cleveland Clinic placenta encapsulation review.

Article Highlighs

• The only real consumer-facing placenta cost is the price of optional encapsulation or keepsake services, which runs $250–$600+ depending on provider and add-ons.
• Parents are not paid for placenta donation in the United States. Tissue banks accept donations at no cost and provide no compensation to the donor.
• Private resale of a placenta is not legally supported under U.S. tissue regulations. The viral $50,000 figure has no authoritative basis in any source reviewed for this article.
• The FDA’s September 2024 warning and the CDC’s 2017 case report are the two most concrete public-record documents on placenta-derived product safety. Both support caution.
• Claimed postpartum benefits of encapsulation are not backed by strong clinical evidence as of May 2025, per Cleveland Clinic’s review.
• Anyone considering encapsulation should confirm hospital release policies, get an itemized quote, and discuss the decision with their OB or midwife before committing.
• The downstream biomedical value of placental tissue in licensed manufacturing does not translate into a lawful payment to the birth parent.

Answers to Common Questions

Can I sell my placenta in the United States?

No. U.S. tissue regulations, including FDA oversight of human cells, tissues, and cellular and tissue-based products, block private commercial sale of a placenta. The Parent’s Guide to Cord Blood Foundation and Gift of Life Michigan both state this clearly. The large figures circulating on social media are not supported by any government, medical, or tissue-bank source reviewed for this article.

How much does placenta encapsulation cost?

Base encapsulation service costs $350 at Midwest Placenta Encapsulation as of 2025. Add-ons such as keepsakes, tinctures, and printed certificates add $50–$150 per item. Shipping, rush processing, and travel fees are charged separately by most providers. A realistic all-in cost for base service plus one keepsake is $375–$420. Prices vary by region and provider.

Is placenta encapsulation safe?

The CDC documented a case of late-onset infant Group B Streptococcus infection in Oregon in 2016 linked to maternal consumption of dehydrated placenta capsules. The encapsulation process does not necessarily eliminate infectious pathogens. The FDA issued a warning on September 4, 2024, about unapproved products derived from human cells and tissues, including placental products. Infection is the most concrete documented risk. Claimed benefits such as improved postpartum recovery or increased milk supply are not backed by strong clinical evidence.

What happens to a placenta if I don’t request it?

The placenta is handled by the hospital as biological waste unless you request otherwise. You can request that it be released to you for encapsulation, or you can donate it to a tissue bank at no cost. Hospital policies on placenta release vary, so confirm your facility’s rules in advance.

Does donating a placenta pay anything?

No. Gift of Life Michigan and other tissue donation organizations state clearly that placenta donation is a no-cost option with no payment to the donor. Donation may support healing applications and research, but parents receive no compensation.